跳至主要内容
临床试验/ISRCTN36463274
ISRCTN36463274已完成不适用

A randomised trial to assess the efficacy of arthemeter lumifantrine and dihydroartemisinin-piperquine in the treatment of uncomplicated malaria and its effects on transmission in Kenya

Royal Tropical Institute (KIT) (The Netherlands)0 个研究点目标入组 150 人开始时间: 2007年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age six months to 12 years
  • 2. Resident in research area and able to complete follow up
  • 3. Temperature higher than 37.5°C but lower than 39.5°C or history of fever in last 24 hours
  • 4. Understanding the procedures of the study by parents or guardian (informed consent)
  • 5. Diagnosed with uncomplicated malaria (P. falciparum) only
  • 6. Parasitaemia 100 - 100.000 parasites/ul

排除标准

  • 1. General danger signs, severe malaria or severe anaemia
  • 2. Severe malnutrition
  • 3. Presence of diseases other than malaria causing febrile conditions
  • 4. Unwilling to participate and sign informed consent form

研究者

发起方
Royal Tropical Institute (KIT) (The Netherlands)

相似试验